VOYA Investment Management’s Nurix Therapeutics NRIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $236K | Buy |
20,714
+1,291
| +7% | +$14.7K | ﹤0.01% | 2259 |
|
|
2025
Q1 | $231K | Sell |
19,423
-35,656
| -65% | -$424K | ﹤0.01% | 2244 |
|
|
2024
Q4 | $1.04M | Buy |
55,079
+34,811
| +172% | +$656K | ﹤0.01% | 1578 |
|
|
2024
Q3 | $455K | Buy |
20,268
+83
| +0.4% | +$1.87K | ﹤0.01% | 2044 |
|
|
2024
Q2 | $421K | Buy |
20,185
+4,200
| +26% | +$87.7K | ﹤0.01% | 2095 |
|
|
2024
Q1 | $235K | Sell |
15,985
-22,471
| -58% | -$330K | ﹤0.01% | 2383 |
|
|
2023
Q4 | $397K | Buy |
38,456
+5,486
| +17% | +$56.6K | ﹤0.01% | 2193 |
|
|
2023
Q3 | $259K | Buy |
32,970
+2,898
| +10% | +$22.8K | ﹤0.01% | 2389 |
|
|
2023
Q2 | $300K | Buy |
30,072
+12,041
| +67% | +$120K | ﹤0.01% | 2367 |
|
|
2023
Q1 | $160K | Hold |
18,031
| – | – | ﹤0.01% | 2600 |
|
|
2022
Q4 | $198K | Hold |
18,031
| – | – | ﹤0.01% | 2576 |
|
|
2022
Q3 | $235K | Buy |
18,031
+1,158
| +7% | +$15.1K | ﹤0.01% | 2500 |
|
|
2022
Q2 | $214K | Buy |
16,873
+4,647
| +38% | +$58.9K | ﹤0.01% | 2361 |
|
|
2022
Q1 | $171K | Hold |
12,226
| – | – | ﹤0.01% | 2409 |
|
|
2021
Q4 | $354K | Sell |
12,226
-132
| -1% | -$3.82K | ﹤0.01% | 2206 |
|
|
2021
Q3 | $370K | Hold |
12,358
| – | – | ﹤0.01% | 2223 |
|
|
2021
Q2 | $328K | Buy |
12,358
+1,917
| +18% | +$50.9K | ﹤0.01% | 2333 |
|
|
2021
Q1 | $325K | Buy |
+10,441
| New | +$325K | ﹤0.01% | 2280 |
|